|
KMID : 0379520220380040591
|
|
한국독성학회지
2022 Volume.38 No. 4 p.591 ~ p.600
|
|
|
Induction of synergistic apoptosis by tetramethoxystilbene and nutlin-3a in human cervical cancer cells
|
|
An Hong-Gyu
Shin Sang-Yun
Lee Bo-Young
Kwon Yeon-Ju
Kwon Tae-Uk
Kwon Yeo-Jung
Chun Young-Jin
|
|
|
Abstract
|
|
|
|
2,4,3’,5′-Tetramethoxystilbene (TMS) is a selective inhibitor of cytochrome P450 1B1 to block the conversion from estradiol to 4-OH-estradiol. Several studies suggested that TMS may act as a potent anti-cancer agent for hormone-related cancer including cervical cancer. Nutlin-3a is a cis-imidazoline analog that interferes with the interaction between mouse double minute 2 homolog (MDM2) and the tumor suppressor p53. The purpose of the study was to compare the cytotoxic effect of TMS and nutlin-3a treatment individually and in combination in HeLa cells. To assess the potential synergistic effects between TMS and nutlin-3a, low concentrations of TMS and nutlin-3a were simultaneously treated in HeLa cells. Based on cell viability, apoptosis assays, and the increase in cleaved caspase-3 and poly (ADP-ribose) polymerase cleavage, it was demonstrated that the combination with TMS and nutlin-3a exerts a synergistic effect on cancer cell death. Isobologram analysis of HeLa cells noted synergism between TMS and nutlin-3a. The combined treatment increased the expression of mitochondrial pro-apoptotic factors such as Bax and Bak, and decreased the expression of the XIAP. In addition, combination treatment significantly enhanced the translocation of AIF to the nucleus in HeLa cells. In conclusion, the results demonstrate that the combination of TMS and nutlin-3a induces synergistic apoptosis in HeLa cells, suggesting the possibility that this combination can be applied as a novel therapeutic strategy for cervical cancer.
|
|
|
KEYWORD
|
|
|
Tetramethoxystilbene, CYP1B1, nutlin-3a, p53, Combination treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|